olmesartan has been researched along with Injury, Myocardial Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, YW; Chen, KB; Lu, X | 1 |
| Dai, W; Hale, SL; Jyrala, AJ; Kay, GL; Kloner, RA | 1 |
| Ichihara, K; Kaneta, S; Kano, S; Satoh, K | 1 |
3 other study(ies) available for olmesartan and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Olmesartan restores the protective effect of remote ischemic perconditioning against myocardial ischemia/reperfusion injury in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Imidazoles; Ischemic Preconditioning, Myocardial; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Inbred SHR; Tetrazoles | 2015 |
Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Imidazoles; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasodilator Agents; Ventricular Function, Left | 2010 |
Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Dogs; Female; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardial Stunning; Myocardium; Pyridines; Receptor, Angiotensin, Type 2; Tetrazoles | 2008 |